GL1X · GenesisL1 explorer

UniProt Q92974

Rho guanine nucleotide exchange factor 2 (Q92974)

Rho guanine nucleotide exchange factor 2 (UniProt Q92974): 33 experimental structures and 1 predicted model on GenesisL1, 20 ligands bound, 136 pockets. Binding sites, druggability and experiment against prediction (TM-score) in…

UniProt
Q92974
Protein
Rho guanine nucleotide exchange factor 2
Experimental structures
33
Predicted models
1
Ligands
20
Pockets
136 · 29 records with a druggable one

Structures

34 records of Q92974 in the MolNFT archive: 33 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
5EFXCrystal structure of Rho GTPase regulatorx-ray diffractionA——
5EFXCrystal structure of rho GTPase regulatorx-ray diffractionA——
7G82ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1079512010x-ray diffractionBUWS4 (best 0.67)
7G83ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z108545814x-ray diffractionB—4 (best 0.68)
7G84ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1102357527x-ray diffractionB—5 (best 0.68)
7G86ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1137725943x-ray diffractionBYXB5 (best 0.66)
7G87ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1148165337x-ray diffractionB—5 (best 0.67)
7G8AARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z100642432x-ray diffractionBWJ7—
7G8BARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z100643660x-ray diffractionBLFO4 (best 0.66)
7G8DARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z104474228x-ray diffractionB60P5 (best 0.67)
7G8KARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1217131798x-ray diffractionBYZK4 (best 0.66)
7G8QARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1269220427x-ray diffractionBZ2Z5 (best 0.67)
7G8RARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1270087714x-ray diffractionB—5 (best 0.67)
7G8SARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1270393711x-ray diffractionBZ5C5 (best 0.67)
7G8UARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z131833926x-ray diffractionBZ3O4 (best 0.67)
7G8VARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z133716556x-ray diffractionB—5 (best 0.67)
7G8XARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1416571195x-ray diffractionB—4 (best 0.68)
7G8YARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1449748885x-ray diffractionB—4 (best 0.67)
7G90ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1509195674x-ray diffractionB—5 (best 0.66)
7G94ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1575337975x-ray diffractionBZC94 (best 0.68)
7G95ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z165170770x-ray diffractionBW0Y4 (best 0.67)
7G96ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z1203730981x-ray diffractionBZCI3 (best 0.68)
7G97ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z57899718x-ray diffractionB—5 (best 0.63)
7G98ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with Z4605084898x-ray diffractionBZDL6 (best 0.59)
7G99ARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102102-001x-ray diffractionBZE96 (best 0.59)
7G9AARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102113-001x-ray diffractionBZEK5 (best 0.65)
7G9BARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102116-001x-ray diffractionBZG05 (best 0.66)
7G9DARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102179-001x-ray diffractionBT7Y4 (best 0.66)
7G9EARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102197-001x-ray diffractionBZG65 (best 0.66)
7G9GARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102236-001x-ray diffractionBZGK5 (best 0.67)
7G9IARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102253-001x-ray diffractionB—5 (best 0.67)
7G9JARHGEF2 PanDDA analysis group deposition -- ARHGEF2 and RhoA in complex with PCM-0102281-001x-ray diffractionBZGX6 (best 0.66)
8BNTThe DH domain of ARHGEF2 bound to RhoAx-ray diffractionB——
Q92974AlphaFold monomer V2.0 prediction for rho guanine nucleotide exchange factor 2 (Q92974)predictedA——

Ligands

  • 60P · 3-methylthiophene-2-carboxylic acid · in 1 record
  • LFO · N,1-dimethyl-1H-indole-3-carboxamide · in 1 record
  • T7Y · N-[3-(2-oxopyrrolidin-1-yl)phenyl]acetamide · in 1 record
  • UWS · 6-methyl-2-[(3-methyl-1,2-oxazol-5-yl)methyl]pyridazin-3(2H)-one · in 1 record
  • W0Y · N-methyl-4-sulfamoylbenzamide · in 1 record
  • WJ7 · 2-bromo-4-fluoro-N,N-dimethylbenzamide · in 1 record
  • YXB · N-[(1H-indol-4-yl)methyl]ethanamine · in 1 record
  • YZK · (3M)-3-(2-methyl-1H-imidazol-1-yl)pyridine · in 1 record
  • Z2Z · 8-(methanesulfonyl)quinoline · in 1 record
  • Z3O · (3S)-3-{[(4R)-4-methyl-3,4-dihydropyridin-1(2H)-yl]methyl}-3H-indole · in 1 record
  • Z5C · 5-(methoxymethyl)-1,2-oxazole-3-carboxamide · in 1 record
  • ZC9 · (2P)-5-fluoro-2-(1H-pyrazol-5-yl)pyridine · in 1 record
  • ZCI · 2-bromo-1H-imidazole · in 1 record
  • ZDL · 1,3-dimethylimidazolidine · in 1 record
  • ZE9 · 1-[(3R,5R)-5-(furan-2-yl)-3-(5-methylfuran-2-yl)pyrazolidin-1-yl]ethan-1-one · in 1 record
  • ZEK · 3-acetamido-N-methylbenzamide · in 1 record
  • ZG0 · N-(3-methylphenyl)acetamide · in 1 record
  • ZG6 · N-(3-methyl-1,2-oxazol-5-yl)acetamide · in 1 record
  • ZGK · N-(2-methoxyphenyl)acetamide · in 1 record
  • ZGX · 1-(3,4-dihydropyrazin-1(2H)-yl)ethan-1-one · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.